Norway vs Singapore: Cause of death, by non-communicable diseases, ages 5-14, female
Norway
71.3%
in 2021
Singapore
73.2%
in 2021
Norway rank
10th
Singapore rank
8th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Norway
- Singapore
How they compare
Singapore currently reports 73.2% against 71.3% in Norway, a difference of 1.9%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Singapore ahead.
Norway ranks 10th and Singapore ranks 8th of 184 countries.
Across the 3 decades both report, Norway averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | Norway | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.5% | 54.3% | 9.8% | Singapore |
| 2010s | 75.6% | 77.1% | 1.5% | Singapore |
| 2020s | 69.7% | 60.0% | 9.7% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Norway or Singapore?
- Singapore, at 73.2% against 71.3% in Norway as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Norway and Singapore?
- 1.9%, with Singapore ahead.
- How many years of comparable data are there for Norway and Singapore?
- 6 years are reported by both, from 2000 to 2021.
- How do Norway and Singapore rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Norway ranks 10th and Singapore ranks 8th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.